Elevated serum cobalamin in patients with decompensated biventricular failure

American Journal of the Medical Sciences

Volumn 336, Issue 5, 2008, Pages 383-388

  Zafarullah, Haris ^a   Shahbaz, Atta U ^a   Alturkmani, Ragheed ^a   Laguardia, Stephen P ^a   Paulus, Basil M ^a   Battin, David L ^a   Afzal, M Omer ^a   Davis, Richard C ^a   Smith, J Lacey ^a   Weber, Karl T ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Heart failure; Liver; Veins

Indexed keywords

ALANINE AMINOTRANSFERASE; ALDOSTERONE ANTAGONIST; ALKALINE PHOSPHATASE; ANGIOTENSIN RECEPTOR ANTAGONIST; ASPARTATE AMINOTRANSFERASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILIRUBIN; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; COBALAMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; LOOP DIURETIC AGENT; SPIRONOLACTONE; CYANOCOBALAMIN; VITAMIN B COMPLEX;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD LEVEL; BRAIN LEVEL; CAVA VEIN DISEASE; CHOLESTASIS; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DECOMPENSATED BIVENTRICULAR FAILURE; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INFERIOR VENA CAVA DILATION; ISCHEMIC HEART DISEASE; LIVER DYSFUNCTION; LIVER NECROSIS; MALE; PERICARDITIS; TRICUSPID VALVE REGURGITATION; VENOUS CONGESTION; VITAMIN BLOOD LEVEL; BLOOD; HEART VENTRICLE FUNCTION; LIVER; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; FEMALE; HEART FAILURE; HUMANS; LIVER; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; VENTRICULAR DYSFUNCTION; VITAMIN B 12; VITAMIN B COMPLEX; YOUNG ADULT;

EID: 58149188698     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MAJ.0000310651.34229.73     Document Type: Article

References (36)

1. Fishman AP. Heart failure. In: Beeson PB, McDermott W, Wyngaarden JB, editors. Cecil textbook of medicine, 15th ed. Philadelphia: W. B. Saunders; 1979. p. 1080-107.
2. Braunwald E. Valvular heart disease. In: Braunwald E, editor. Heart disease: a textbook of cardiovascular medicine, 3rd ed. Philadelphia: WB Saunders; 1988. p. 1023-92.
3. Weber KT. Aldosterone in congestive heart failure. N Engl J Med 2001;345:1689-97.
4. Sherlock S. The liver in heart failure; relation of anatomical, functional, and circulatory changes. Br Heart J 1951;13:273-93.
5. Hudson REB. Changes in various organs in congestive heart failure. In: Hudson REB, editor. Cardiovascular pathology, Vol. 1. Baltimore: Williams & Wilkins; 1965. p. 267-73.
6. Anker SD, Chua TP, Ponikowski P, et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 1997;96:526-34.
7. Ajayi AA, Adigun AQ, Ojofeitimi EO, et al. Anthropometric evaluation of cachexia in chronic congestive heart failure: the role of tricuspid regurgitation. Int J Cardiol 1999;71:79-84.
8. Killip T III, Payne MA. High serum transaminase activity in heart disease. Circulatory failure and hepatic necrosis. Circulation 1960;21:646-60.
9. Henrion J, Descamps O, Luwaert R, et al. Hypoxic hepatitis in patients with cardiac failure: incidence in a coronary care unit and measurement of hepatic blood flow. J Hepatol 1994;21:696-703.
10. Seeto RK, Fenn B, Rockey DC. Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med 2000;109:109-13.
11. 12). In: Shils ME, Shike M, Ross AC, et al, editors. Modern nutrition in health and disease, 10 ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 482-97.
12. 12) and holotranscobalamin changes in plasma and liver tissue in alcoholics with liver disease. J Am Coll Nutr 1998;17:235-8.
13. 12 titres as indicators of disease severity and mortality of patients with alcoholic hepatitis. Alcohol Alcohol 1987;22:1-5.
14. Carmel R, Vasireddy H, Aurangzeb I, et al. High serum cobalamin levels in the clinical setting - clinical associations and holo-transcobalamin changes. Clin Lab Haematol 2001; 23:365-71.
15. 12) as an index of hepatic damage in chronic congestive heart failure. Arch Intern Med 1959;104: 406-10.
16. Herrmann M, Muller S, Kindermann I, et al. Plasma B vitamins and their relation to the severity of chronic heart failure. Am J Clin Nutr 2007;85:117-23.
17. Seetharam B. Receptor-mediated endocytosis of cobalamin (vitamin B12). Annu Rev Nutr 1999;19:173-95.
18. Soda R, Tavassoli M, Jacobsen DW. Receptor distribution and the endothelial uptake of transcobalamin II in liver cell suspensions. Blood 1985;65:795-802.
19. 12 assay, serum. In: Leavelle DE, editor. Mayo medical laboratories interpretive handbook. Rochester (MN): Mayo Medical Laboratories; 2001. p. 668-9.
20. ArcidiJMJr, Moore GW, Hutchins GM. Hepatic morphology in cardiac dysfunction: a clinicopathologic study of 1000 subjects at autopsy. Am J Pathol 1981;104:159-66.
21. Lau GT, Tan HC, Kritharides L. Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. Am J Cardiol 2002;90:1405-9.
22. 12 in the normal and diseased liver. Gastroenterology 1959;36:180-90.
23. Rachmilewitz M, Aronovitch J, Grossowicz N. Serum concentrations of vitamin B12 in acute and chronic liver disease. J Lab Clin Med 1956;48:339-44.
24. 12 concentrations. J Lab Clin Med 1957; 49:910-22.
25. Lieberman J, Lasky II, Dulkin SI, et al. Serum glutamicoxalacetic transaminase activity in conditions associated with myocardial infarction. II. Cerebral vascular accidents and congestive heart failure. Ann Intern Med 1957;46:497-505.
26. Chinsky M, Sherry S. Serum transaminase as a diagnostic aid. AMA Arch Intern Med 1957;99:556-68.
27. Bang NU, Iversen K, Jagt T, et al. Serum glutamic-oxaloacetic transaminase activity as an index of centrilobular liver cell necrosis in cardiac and circulatory failure. Acta Med Scand 1959;164:385-93.
28. West M, Gelb D, Pilz CG, et al. Serum enzymes in disease. VII. Significance of abnormal serum enzyme levels in cardiac failure. Am J Med Sci 1961;241:350-8.
29. Cantarow A. Studies of hepatic function. II. In portal cirrhosis and congestive heart failure. Arch Intern Med 1935; 56:521-9.
30. Chávez I, Sepú lveda B, Ortega A. The functional value of the liver in heart disease. An experimental study. J Am Med Assoc 1943;121:1276-82.
31. Batin P, Wickens M, McEntegart D, et al. The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure. Eur Heart J 1995;16:1613-18.
32. Dichtl W, Vogel W, Dunst KM, et al. Cardiac hepatopathy before and after heart transplantation. Transpl Int 2005;18: 697-702.
33. Lee SW, Song JH, Kim GA, et al. Plasma brain natriuretic peptide concentration on assessment of hydration status in hemodialysis patient. Am J Kidney Dis 2003;41:1257-66.
34. Baxter GF. Natriuretic peptides and myocardial ischaemia. Basic Res Cardiol 2004;99:90-3.
35. Campos PC, D'Cruz IA, Johnson LS, et al. Functional valvular incompetence in decompensated heart failure. Non-invasive monitoring and response to medical management. Am J Med Sci 2005;329:217-21.
36. Ermens AA, Vlasveld LT, Lindemans J. Significance of elevated cobalamin (vitamin B12) levels in blood. Clin Biochem 2003;36:585-90.